These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11249133)

  • 1. Synthesis and evaluation of A-ring diastereomers of 1alpha,25-dihydroxy-22-oxavitamin D3 (OCT).
    Hatakeyama S; Okano T; Maeyama J; Esumi T; Hiyamizu H; Iwabuchi Y; Nakagawa K; Ozono K; Kawase A; Kubodera N
    Bioorg Med Chem; 2001 Feb; 9(2):403-15. PubMed ID: 11249133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activities of 2alpha-substituted analogues of 1alpha,25-dihydroxyvitamin D3 in transcriptional regulation and human promyelocytic leukemia (HL-60) cell proliferation and differentiation.
    Takahashi E; Nakagawa K; Suhara Y; Kittaka A; Nihei K; Konno K; Takayama H; Ozono K; Okano T
    Biol Pharm Bull; 2006 Nov; 29(11):2246-50. PubMed ID: 17077522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic studies of vitamin D analogs. XXII. Synthesis and antiproliferation activity of putative metabolites of 1 alpha, 25-dihydroxy-22-oxavitamin D3.
    Watanabe H; Hatakeyama S; Tazumi K; Takano S; Masuda S; Okano T; Kobayashi T; Kubodera N
    Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2280-6. PubMed ID: 8996858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 20-epi-2-methyl-1alpha,25-dihydroxyvitamin D(3).
    Takayama H; Konno K; Fujishima T; Maki S; Liu Z; Miura D; Chokki M; Ishizuka S; Smith C; DeLuca HF; Nakagawa K; Kurobe M; Okano T
    Steroids; 2001; 66(3-5):277-85. PubMed ID: 11179735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic studies of vitamin D analogues. XVII. Synthesis and differentiation-inducing activity of 1 alpha,24-dihydroxy-22-oxavitamin D3 analogues and their 20(R)-epimers.
    Kubodera N; Watanabe H; Miyamoto K; Matsumoto M; Matsuoka S; Kawanishi T
    Chem Pharm Bull (Tokyo); 1993 Sep; 41(9):1659-63. PubMed ID: 8221979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
    Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
    Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly potent cell differentiation-inducing analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological activity of 2-methyl-1,25-dihydroxyvitamin D3 with side-chain modifications.
    Fujishima T; Zhaopeng L; Konno K; Nakagawa K; Okano T; Yamaguchi K; Takayama H
    Bioorg Med Chem; 2001 Feb; 9(2):525-35. PubMed ID: 11249144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of all possible A-ring diastereomers at the 1- and 3-positions of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71) using C2-symmetrical epoxide as a common starting material.
    Kubodera N; Hatakeyama S
    Anticancer Res; 2009 Sep; 29(9):3571-8. PubMed ID: 19667150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
    Arai MA; Kittaka A
    Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
    Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
    Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 1alpha,24-dihydroxy-25-nitrovitamin D3.
    Oshida J; Okamoto M; Ishizuka S; Azuma S
    Bioorg Med Chem Lett; 1999 Feb; 9(3):381-4. PubMed ID: 10091688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells.
    Ono K; Yoshida A; Saito N; Fujishima T; Honzawa S; Suhara Y; Kishimoto S; Sugiura T; Waku K; Takayama H; Kittaka A
    J Org Chem; 2003 Sep; 68(19):7407-15. PubMed ID: 12968893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic studies of vitamin D analogues. XI. Synthesis and differentiation-inducing activity of 1 alpha,25-dihydroxy-22-oxavitamin D3 analogues.
    Kubodera N; Watanabe H; Kawanishi T; Matsumoto M
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1494-9. PubMed ID: 1327561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.
    Messerlian S; Gao X; St-Arnaud R
    J Steroid Biochem Mol Biol; 2000; 72(1-2):29-34. PubMed ID: 10731635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of 2-methyl-20-epi analogues of 1 alpha,25-dihydroxyvitamin D3.
    Fujishima T; Liu Z; Miura D; Chokki M; Ishizuka S; Konno K; Takayama H
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2145-8. PubMed ID: 9873502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (23S)- and (23R)-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactone function as antagonists of vitamin D receptor-mediated genomic actions of 1alpha,25-dihydroxyvitamin D(3).
    Ishizuka S; Miura D; Ozono K; Saito M; Eguchi H; Chokki M; Norman AW
    Steroids; 2001; 66(3-5):227-37. PubMed ID: 11179730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient synthesis and biological evaluation of all A-ring diastereomers of 1alpha,25-dihydroxyvitamin D3 and its 20-epimer.
    Fujishima T; Konno K; Nakagawa K; Kurobe M; Okano T; Takayama H
    Bioorg Med Chem; 2000 Jan; 8(1):123-34. PubMed ID: 10968271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.
    Fujishima T; Tsutsumi R; Negishi Y; Fujii S; Takayama H; Kittaka A; Kurihara M
    Anticancer Res; 2006; 26(4A):2633-6. PubMed ID: 16886673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activities of 26-hydroxy-27-nor-derivatives of 1 alpha, 25-dihydroxyvitamin D3.
    Scheddin D; Mayer H; Wittmann S; Schönecker B; Gliesing S; Reichenbächer M
    Steroids; 1996 Oct; 61(10):598-608. PubMed ID: 8910973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro biological activities of a series of 2 beta-substituted analogues of 1 alpha,25-dihydroxyvitamin D3.
    Tsugawa N; Nakagawa K; Kurobe M; Ono Y; Kubodera N; Ozono K; Okano T
    Biol Pharm Bull; 2000 Jan; 23(1):66-71. PubMed ID: 10706413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.